新藥研發產業博士學位學程

Medicine & Life Sciences

1. Neoplasms 97%
2. Taiwan 92%
3. Histone Deacetylase Inhibitors 86%
4. Apoptosis 84%
5. Proteins 68%
6. In Vitro Techniques 67%
7. Growth 60%
8. Lipopolysaccharides 58%
9. Phosphorylation 57%
10. Inhibitory Concentration 50 55%
11. Therapeutics 52%
12. Glioblastoma 49%
13. Colorectal Neoplasms 48%
14. Genes 48%
15. Cell Line 46%
16. Autophagy 44%
17. Cyclooxygenase 2 44%
18. Histone Deacetylases 43%
19. Down-Regulation 43%
20. Antioxidants 39%
21. Blood Platelets 38%
22. Cell Proliferation 37%
23. Cell Movement 37%
24. Anti-Inflammatory Agents 37%
25. Macrophages 36%
26. Breast Neoplasms 36%
27. Pharmaceutical Preparations 35%
28. Lung Neoplasms 34%
29. Gene Expression 34%
30. Up-Regulation 34%
31. Inflammation 34%
32. Lung 34%
33. Antineoplastic Agents 33%
34. Non-Small Cell Lung Carcinoma 33%
35. Fibroblasts 32%
36. Population 31%
37. Phosphotransferases 31%
38. Mucocutaneous Lymph Node Syndrome 31%
39. Cell Death 30%
40. Kidney 30%
41. Heterografts 29%
42. Tubulin 28%
43. p38 Mitogen-Activated Protein Kinases 28%
44. Nanoparticles 27%
45. Nitric Oxide 27%
46. Nitric Oxide Synthase Type II 27%
47. Oxidative Stress 27%
48. Connective Tissue Growth Factor 27%
49. Reactive Oxygen Species 26%
50. Bone and Bones 26%
51. Matrix Metalloproteinases 26%
52. Messenger RNA 25%
53. osthol 25%
54. Protein Kinase C 25%
55. Hepatocellular Carcinoma 24%
56. Epithelial Cells 24%
57. Temozolomide 24%
58. Biomarkers 24%
59. Neoplasm Metastasis 24%
60. Tubulin Modulators 24%
61. Interleukin-1 23%
62. Cytokines 23%
63. Matrix Metalloproteinase 9 23%
64. Glioma 23%
65. Smooth Muscle Myocytes 23%
66. Microtubules 22%
67. Endothelial Cells 22%
68. Extracellular Signal-Regulated MAP Kinases 22%
69. A549 Cells 22%
70. Caspase 3 22%
71. Thrombin 22%
72. Stem Cells 21%
73. Triple Negative Breast Neoplasms 21%
74. Activating Transcription Factor 3 21%
75. Western Blotting 20%
76. MicroRNAs 20%
77. High Pressure Liquid Chromatography 20%
78. Cell Cycle 20%
79. Platelet Aggregation 20%
80. Serum 20%
81. Cohort Studies 20%
82. Transcription Factor AP-1 20%
83. Interleukin-8 20%
84. Resveratrol 20%
85. Cell Survival 20%
86. Magnetic Fields 20%
87. Cell Cycle Checkpoints 20%
88. Prostatic Neoplasms 19%
89. indoline 19%
90. Colonic Neoplasms 19%
91. Peroxisome Proliferator-Activated Receptors 19%
92. Vascular Smooth Muscle 19%
93. Single-Chain Antibodies 19%
94. Liver 19%
95. Human Umbilical Vein Endothelial Cells 19%
96. Stroke 19%
97. DNA 19%
98. Carcinogenesis 18%
99. Dinoprostone 18%
100. Small Interfering RNA 18%

Chemical Compounds

1. Protein 100%
2. Histone 63%
3. Drug 44%
4. Antiproliferative 41%
5. Cell Death 37%
6. Antineoplastic Agent 34%
7. Antioxidant Agent 32%
8. Antiinflammatory 30%
9. Antitumor 29%
10. Apoptotic 26%
11. Nitric Oxide 25%
12. Lipopolysaccharide 25%
13. Marker 24%
14. Growth Factor 22%
15. Application 22%
16. Reactive Oxygen Metabolite 22%
17. Resistance 22%
18. Biological Marker 22%
19. Oxidative Stress 21%
20. Disorder 20%
21. Plasma 20%
22. Genetic Polymorphism 20%
23. Cell Viability 19%
24. 50 Percent Growth Inhibition 19%
25. Acid 18%
26. Protective 18%
27. Hydroxamic Acid 18%
28. Metabolic 17%
29. Leaf Like Crystal 17%
30. Dose 17%
31. Metabolite 16%
32. Pharmacological Metabolism 16%
33. Temozolomide 16%
34. Collagen 15%
35. Bioavailability 15%
36. Fermentation 15%
37. Flavonoid 14%
38. Hyaluronic Acid 14%
39. Anticoagulant Agent 14%
40. Glucose 14%
41. Bioactivity 13%
42. Weight 13%
43. Osthole 13%
44. Retinal 13%
45. Flow 13%
46. Colchicine 12%
47. Calcium(0) 12%
48. Polymerization Reaction 12%
49. MicroRNA 11%
50. Antroquinonol 11%
51. High-Pressure Liquid Chromatography 11%
52. Molecule 11%
53. Implant 11%
54. Acetylation 11%
55. Hydrogel 11%
56. Vascular Targeting Agent 11%
57. Oncogenic 11%
58. Trichostatin A 11%
59. Modification 11%
60. Resveratrol 11%
61. Cantharidin 11%
62. Cleavage 11%
63. Nanoparticle 11%
64. Andrographolide 10%
65. Western Blotting 10%
66. Neuroprotective 10%
67. Food 10%
68. Quercetin 10%
69. Structure-Activity Relationship 10%
70. Chain Reaction 10%
71. Surface 10%
72. Cytometry 10%
73. Time 10%
74. Aristolochic Acid 10%
75. Mutation 9%
76. Nanocarrier 9%
77. Endothelin-1 9%
78. Pharmacokinetics 9%
79. Lipid 9%
80. Growth Inhibition 9%
81. Free Radical 9%
82. Occurrence in Nature 9%
83. Spectroscopic Analysis 9%
84. Composite Material 9%
85. Peptide 9%
86. Antimicrobial Agent 9%
87. Membrane Potential 8%
88. Heat 8%
89. Angiogenic 8%
90. Estrogen 8%
91. Prostaglandin E2 8%
92. Methylglyoxal 8%
93. Reduction 8%
94. Antiacne 8%
95. Binding Site 8%
96. Amount 8%
97. 3-Hydroxybutyrate 8%
98. Poly(ADPribose) 8%